Aridis Pharmaceuticals Inc. announced the appointment of Fred Kurland, a seasoned pharmaceutical executive, as the company's first Chief Financial Officer. Prior to joining the company, Fred Kurland served as Chief Financial Officer, Vice President of Finance and Secretary of XOMA Corporation since December 2008. He was responsible for directing the company's financial strategies and financing activities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | +8.89% |
|
-21.57% | -14.41% |
Jun. 24 | Aridis Pharmaceuticals, Inc. Provides Corporate Update on Recent Developments | CI |
Jun. 24 | Aridis Pharmaceuticals, Inc. announced that it expects to receive $0.299 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-14.41% | 3.2M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- ARDS Stock
- News Aridis Pharmaceuticals, Inc.
- Aridis Pharmaceuticals Inc. Appoints Fred Kurland as Chief Financial Officer